DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 132 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $261,000 | -95.2% | 66,091 | -87.3% | 0.02% | -92.7% |
| Q3 2016 | $5,474,000 | +29.2% | 521,875 | +79.6% | 0.20% | -7.2% |
| Q2 2016 | $4,236,000 | +0.1% | 290,505 | +32.0% | 0.22% | +4.2% |
| Q1 2016 | $4,233,000 | +46.0% | 220,000 | +83.3% | 0.21% | +33.3% |
| Q4 2015 | $2,899,000 | -12.5% | 120,000 | -11.1% | 0.16% | +16.9% |
| Q3 2015 | $3,312,000 | +102.0% | 134,954 | +92.8% | 0.14% | +126.7% |
| Q2 2015 | $1,640,000 | – | 70,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |